Therapeutic pathology
71 – 80 of 158
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters
- Contribution to journal › Article
-
Mark
Re-evaluation of HER2 status in 606 breast cancers—gene protein assay on tissue microarrays versus routine pathological assessment
- Contribution to journal › Article
-
Mark
Inflammatory macrophage derived TNFα downregulates estrogen receptor α via FOXO3a inactivation in human breast cancer cells
- Contribution to journal › Article
-
Mark
Complement inhibitor factor H expressed by breast cancer cells differentiates CD14+ human monocytes into immunosuppressive macrophages
- Contribution to journal › Article
-
Mark
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
- Contribution to journal › Article
-
Mark
Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas
- Contribution to journal › Article
-
Mark
LGR5 in breast cancer and ductal carcinoma in situ : a diagnostic and prognostic biomarker and a therapeutic target
- Contribution to journal › Article
-
Mark
Tumor-Associated CD68+, CD163+, and MARCO+ Macrophages as Prognostic Biomarkers in Patients With Treatment-Naïve Gastroesophageal Adenocarcinoma
- Contribution to journal › Article
-
Mark
Diagnostic value of insulinoma-associated protein 1 (INSM1) and comparison with established neuroendocrine markers in pulmonary cancers
- Contribution to journal › Article
-
Mark
Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation : Implications for risk stratification of bladder cancer
- Contribution to journal › Article
